This inventor holds 1 USPTO granted patent. Top assignee: Ea Pharma Co., Ltd.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Kana Iwasaki: Innovator in Alpha-4 Beta-7 Integrin Inhibition
Introduction
Kana Iwasaki is a notable inventor based in Chuo-ku, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that inhibit alpha-4 beta-7 integrin activity. Her work is crucial in advancing therapeutic options for various medical conditions.
Latest Patents
Kana Iwasaki holds a patent for "Substituted benzenesulfonamides as inhibitors of alpha-4 beta-7 integrin activity." This patent describes a compound that exhibits α4 integrin inhibitory action. The compound is a sulfonamide derivative represented by a specific formula, which includes various substituents as detailed in the patent specification.
Career Highlights
Kana is currently employed at Ea Pharma Co., Ltd., where she continues to engage in innovative research and development. Her expertise in medicinal chemistry has positioned her as a valuable asset in her field.
Collaborations
Kana has collaborated with notable colleagues, including Munetaka Tokumasu and Masatsugu Noguchi. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Kana Iwasaki's contributions to the field of integrin inhibition exemplify her dedication to innovation in pharmaceutical sciences. Her work not only advances scientific knowledge but also holds promise for future therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile